| 1 |
Cheng M, Ye C, Tian C, Zhao D, Li H, Sun Z, Miao Y, Zhang Q, Wang J, Dou Y. Engineered macrophage-biomimetic versatile nanoantidotes for inflammation-targeted therapy against Alzheimer's disease by neurotoxin neutralization and immune recognition suppression. Bioact Mater 2023;26:337-52. [PMID: 36950153 DOI: 10.1016/j.bioactmat.2023.03.004] [Reference Citation Analysis]
|
| 2 |
Zhang ZY, Yuan X, He HY, He WB, Zhang Z, Chu SF. Upregulation of HBXIP contributed to the anti-DND by ginsenoside Rg1 after global cerebral ischemia-reperfusion. J Pharm Pharmacol 2023;75:437-44. [PMID: 36734364 DOI: 10.1093/jpp/rgac097] [Reference Citation Analysis]
|
| 3 |
Kong L, Sun R, Zhou H, Shi Q, Liu Y, Han M, Li W, Qun S, Li W. Trpc6 knockout improves behavioral dysfunction and reduces Aβ production by inhibiting CN-NFAT1 signaling in T2DM mice. Exp Neurol 2023;363:114350. [PMID: 36791875 DOI: 10.1016/j.expneurol.2023.114350] [Reference Citation Analysis]
|
| 4 |
Nocella C, D'Amico A, Cammisotto V, Bartimoccia S, Castellani V, Loffredo L, Marini L, Ferrara G, Testa M, Motta G, Benazzi B, Zara F, Frati G, Sciarretta S, Pignatelli P, Violi F, Carnevale R, Group S. Structure, Activation, and Regulation of NOX2: At the Crossroad between the Innate Immunity and Oxidative Stress-Mediated Pathologies. Antioxidants (Basel) 2023;12. [PMID: 36829988 DOI: 10.3390/antiox12020429] [Reference Citation Analysis]
|
| 5 |
She L, Xiong L, Li L, Zhang J, Sun J, Wu H, Ren J, Wang W, Zhao X, Liang G. Ginsenoside Rk3 ameliorates Aβ-induced neurotoxicity in APP/PS1 model mice via AMPK signaling pathway. Biomed Pharmacother 2023;158:114192. [PMID: 36587558 DOI: 10.1016/j.biopha.2022.114192] [Reference Citation Analysis]
|
| 6 |
Bian Z, Yu H, Hu X, Bian Y, Sun H, Tadokoro K, Takemoto M, Yunoki T, Nakano Y, Fukui Y, Morihara R, Abe K, Yamashita T. Tocovid Attenuated Oxidative Stress and Cognitive Decline by Inhibiting Amyloid-β-Induced NOX2 Activation in Alzheimer's Disease Mice. J Alzheimers Dis 2022. [PMID: 36565115 DOI: 10.3233/JAD-220761] [Reference Citation Analysis]
|
| 7 |
Ma Y, Li W, Fan C, Wang Y, Jiang H, Yang W. Comprehensive Analysis of Long Non-Coding RNAs N4-Acetylcytidine in Alzheimer's Disease Mice Model Using High-Throughput Sequencing. J Alzheimers Dis 2022;90:1659-75. [PMID: 36314201 DOI: 10.3233/JAD-220564] [Reference Citation Analysis]
|
| 8 |
Dong X, Kong L, Huang L, Su Y, Li X, Yang L, Ji P. Ginsenoside Rg1 treatment protects against cognitive dysfunction via inhibiting PLC–CN–NFAT1 signaling in T2DM mice. Journal of Ginseng Research 2022. [DOI: 10.1016/j.jgr.2022.12.006] [Reference Citation Analysis]
|
| 9 |
Shi Z, Chen H, Zhou X, Yang W, Lin Y. Pharmacological effects of natural medicine ginsenosides against Alzheimer’s disease. Front Pharmacol 2022;13. [DOI: 10.3389/fphar.2022.952332] [Reference Citation Analysis]
|
| 10 |
Yang S, Wang J, Cheng P, Chen L, Hu J, Zhu G. Ginsenoside Rg1 in neurological diseases: From bench to bedside. Acta Pharmacol Sin 2022. [DOI: 10.1038/s41401-022-01022-1] [Reference Citation Analysis]
|
| 11 |
Yan Y, Huang Z, Xiong Q, Song Y, Li S, Yang B, Sun L, Zhang M, Ji Y. Effects of Broussonetia papyrifera (L.) L'Hér. ex Vent. fruits water extract on hippocampal neurogenesis in the treatment of APP/PS1 transgenic mice. Front Pharmacol 2022;13. [DOI: 10.3389/fphar.2022.1056614] [Reference Citation Analysis]
|
| 12 |
Feng H, Xue M, Deng H, Cheng S, Hu Y, Zhou C. Ginsenoside and Its Therapeutic Potential for Cognitive Impairment. Biomolecules 2022;12:1310. [PMID: 36139149 DOI: 10.3390/biom12091310] [Reference Citation Analysis]
|
| 13 |
Liu Y, Huang L, Kim M, Cho JY. The Role of Thymoquinone in Inflammatory Response in Chronic Diseases. IJMS 2022;23:10246. [DOI: 10.3390/ijms231810246] [Reference Citation Analysis]
|
| 14 |
Shen Y, Qian L, Luo H, Li X, Ruan Y, Fan R, Si Z, Chen Y, Li L, Liu Y. The Significance of NLRP Inflammasome in Neuropsychiatric Disorders. Brain Sciences 2022;12:1057. [DOI: 10.3390/brainsci12081057] [Reference Citation Analysis]
|
| 15 |
Wang J, Kong L, Guo RB, He SY, Liu XZ, Zhang L, Liu Y, Yu Y, Li XT, Cheng L. Multifunctional icariin and tanshinone IIA co-delivery liposomes with potential application for Alzheimer's disease. Drug Deliv 2022;29:1648-62. [PMID: 35616263 DOI: 10.1080/10717544.2022.2072543] [Reference Citation Analysis]
|
| 16 |
Wang C, Zheng C. Using Caenorhabditis elegans to Model Therapeutic Interventions of Neurodegenerative Diseases Targeting Microbe-Host Interactions. Front Pharmacol 2022;13:875349. [DOI: 10.3389/fphar.2022.875349] [Reference Citation Analysis]
|
| 17 |
Shao F, Wang X, Wu H, Wu Q, Zhang J. Microglia and Neuroinflammation: Crucial Pathological Mechanisms in Traumatic Brain Injury-Induced Neurodegeneration. Front Aging Neurosci 2022;14:825086. [DOI: 10.3389/fnagi.2022.825086] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 18 |
Mao J, Ma X, Zhu J, Zhang H. Ginsenoside Rg1 ameliorates psoriasis-like skin lesions by suppressing proliferation and NLRP3 inflammasomes in keratinocytes. J Food Biochem 2022;:e14053. [PMID: 35218026 DOI: 10.1111/jfbc.14053] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
|
